Table 3.
Pre- and post-operative scores
| Baseline (N=75)a | 6months post-operatively (N=58) | P-value | Change in scoreb | |
|---|---|---|---|---|
| PFDI | ||||
| UDIc | 61 (52–71) | 15 (10–21) | <0.01 | 70 (55–83) |
| POPDIc | 76 (64–88) | 22 (14–30) | <0.01 | 94 (78–110) |
| CRADIc | 71 (59–84) | 26 (17–34) | <0.01 | 70 (48–75) |
| PFIQ | <0.01 | |||
| UIQc | 76 (61–90) | 35 (21–48) | <0.01 | 60 (41–80) |
| POPIQc | 53 (40–63) | 20 (10–29) | <0.01 | 59 (39–79) |
| CRAIQc | 45 (52–68) | 23 (12–33) | <0.01 | 35 (16–54) |
| POPQ staged | III (0–IV) | 1 (0–IV) | <0.01 | |
| Leading edge of prolapse (cm)e | +3.3±2.1 | −2±1 | <0.01 | |
| PHQ-9d | 3 (0–21) | 2 (0–17) | <0.01 | |
| PHQ-9 >10 | 17 (22.4%) | 5 (9%) | ||
| Any depressive disorder | 14 (18.4%) | 3 (5.4%) | ||
| Major depressive disorder | 11 (14.5%) | 2 (3.6%) |
UIQ, Urinary Impact Questionnaire
a
All baseline data are reported in this column. Change score and comparison of baseline to post-operative scores were calculated using only paired data
b
Change in score: baseline score minus 6-month score
c
Reported as mean scores with 95% CI. P-value from Wilcoxon’s paired samples test
d
Reported as median with range. P-value from Wilcoxon’s paired samples test
e
Reported as mean±SD. P-value from Student’s paired samples t test